Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS
Monday, June 13, 2022Amylyx Pharmaceuticals Inc today announced that Health Canada has approved ALBRIOZA sodium phenylbutyrate and ursodoxicoltaurine with conditions for the treatment of amyotrophic lateral sclerosis ALS Clinical data demonstrated a statistically signifi...
U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
Friday, June 10, 2022Roche today announced that the United States Food and Drug Administration US FDA has approved Foundation Medicines FoundationOneCDx as a companion diagnostic CDx for Roches Rozlytrek entrectinib FoundationOne CDx is a comprehensive genomic profiling...
Ferring Announces New Collaboration for Development of Olamkicept
Friday, June 10, 2022Ferring Pharmaceuticals today announced it has entered into a strategic collaboration with IMab to further develop olamkicept in inflammatory bowel disease IBD and related inflammatory conditions Olamkicept is the first and only clinical stage selec...
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene
Thursday, June 09, 2022Opiant Pharmaceuticals Inc today announced a capacity investment agreement with Aptar Pharma Aptar a leading provider of drug delivery systems to expand production of Aptars nasal Unidose device which will be used in the production of commercial supp...
Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting
Thursday, June 09, 2022Integral Molecular and Optimeos Life Sciences announce a partnership to develop nextgeneration mRNA and DNA therapeutics that will use antibodybased molecular targeting to direct vaccines and gene therapies to relevant tissues in a patients body
Ginkgo Bioworks and Novo Nordisk to Collaborate on Expression Systems for Pharmaceutical Products
Wednesday, June 08, 2022Ginkgo Bioworks the leading horizontal platform for cell programming today announced a collaboration with Novo Nordisk a leading global healthcare company to create novel expression hosts for pharmaceutical products Today hundreds of millions of peop...
BioCryst Announces Approval of ORLADEYO® (berotralstat) by Swissmedic
Wednesday, June 08, 2022BioCryst Pharmaceuticals Inc announced that Swissmedic has granted marketing authorization for oral oncedaily ORLADEYO berotralstat for the routine prevention of recurrent hereditary angioedema HAE attacks in patients years and older in Switzerland...
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea
Tuesday, June 07, 2022Parse Biosciences a leading provider of scalable singlecell sequencing solutions today announced a partnership with Molecular Diagnostics Korea MDxK that will expand its presence in Asia by providing its entire line of Evercode Whole Transcriptome pr...
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018
Tuesday, June 07, 2022Antengene Corporation Limited a leading commercialstage global biopharmaceutical company dedicated to discovering developing and commercializing firstinclass andor bestinclass therapeutics in hematology and oncology today announced that Antengene has...
Biogen and Samsung Bioepis’ BYOOVIZ™ (ranibizumab-nuna) Launches in the United States
Friday, June 03, 2022Biogen Inc and Samsung Bioepis Co Ltd today announced that BYOOVIZ ranibizumabnuna a biosimilar referencing LUCENTIS ranibizumabi has been launched in the United States Healthcare provider engagement promotional activity collaborations with professio...
